Your browser does not allow JavaScript!
JavaScript is necessary for the proper functioning of this website. Please enable JavaScript or use a modern browser.
Open Science Slovenia
Open Science
DiKUL
slv
|
eng
Search
Browse
New in RUL
About RUL
In numbers
Help
Sign in
Interactome of PTH-Regulated miRNAs and their predicted target genes for Investigating the epigenetic effects of PTH (1–34) in bone metabolism
ID
Vrščaj, Lucija Ana
(
Author
),
ID
Marc, Janja
(
Author
),
ID
Ostanek, Barbara
(
Author
)
URL - Source URL, Visit
https://www.mdpi.com/2073-4425/13/8/1443
PDF - Presentation file,
Download
(1,05 MB)
MD5: 11AEA578AD16B4EE294E40C81CB42B23
Image galllery
Abstract
Osteoporosis is a metabolic bone disease that mostly affects the elderly. A lot of drugs are available, mostly with an antiresorptive effect but just a few with an osteoanabolic effect, meaning they promote bone building. PTH (1-34) or teriparatide is an osteoanabolic drug, but its efficacy varies between individuals. We performed a literature review and extracted a dataset of 62 microRNAs (miRNAs) from 10 different studies; predicted miRNA target interactions (MTIs) were obtained with the help of four software tools: DIANA, miRWalk, miRDB and TargetScan. With the construction of an interactome of PTH-regulated miRNAs and their predicted target genes, we elucidated miR-146a-5p, miR-551b-5p, miR-205-3p, miR-33a-3p, miR-338-5p as miRNAs with the most interactions and miR-410-3p as the miRNA targeting bone-related pathways with the highest significance. These miRNAs could help in further understanding the mechanism of action of PTH on bone metabolism and osteoporosis. They also have the potential for novel network-based biomarkers for osteoporosis treatment efficacy and safety and as new therapeutic targets.
Language:
English
Keywords:
osteoporosis
,
osteoporosis treatment
,
microRNA
,
parathyroid hormone
,
teriparatide
,
network
,
Cytoscape
,
biological pathway
,
gene enrichment biomarker
Typology:
1.01 - Original Scientific Article
Organization:
FFA - Faculty of Pharmacy
Publication status:
Published
Publication version:
Version of Record
Publication date:
13.08.2022
Year:
2022
Number of pages:
Str. 1-15
Numbering:
Vol. 13, iss. 8, art. 1443
PID:
20.500.12556/RUL-138758
UDC:
616.71-007.234:616-085
ISSN on article:
2073-4425
DOI:
10.3390/genes13081443
COBISS.SI-ID:
118226947
Publication date in RUL:
16.08.2022
Views:
675
Downloads:
117
Metadata:
Cite this work
Plain text
BibTeX
EndNote XML
EndNote/Refer
RIS
ABNT
ACM Ref
AMA
APA
Chicago 17th Author-Date
Harvard
IEEE
ISO 690
MLA
Vancouver
:
Copy citation
Share:
Record is a part of a journal
Title:
Genes
Shortened title:
Genes
Publisher:
Multidisciplinary Digital Publishing Institute (MDPI)
ISSN:
2073-4425
COBISS.SI-ID:
523100185
Licences
License:
CC BY 4.0, Creative Commons Attribution 4.0 International
Link:
http://creativecommons.org/licenses/by/4.0/
Description:
This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:
16.08.2022
Secondary language
Language:
Slovenian
Keywords:
zdravljenje osteoporoze
,
mikroRNA
,
paratiroidni hormon
,
teriparatid
,
omrežje
,
biomarker za obogatitev genov
,
biološka pot
Projects
Funder:
ARRS - Slovenian Research Agency
Project number:
P3-0298
Name:
Geni, hormonske in osebnostne spremembe pri metabolnih motnjah
Funder:
ARRS - Slovenian Research Agency
Project number:
J3-1759
Name:
Celostna karakterizacija zadetkov analiz GWAS - pot do novih terapevtskih tarč za anabolno zdravljenje osteoporoze(GWASforAna)
Similar documents
Similar works from RUL:
Similar works from other Slovenian collections:
Back